References
- Anderson NL, Anderson NG. (2002). The human plasma proteome. Mol Cell Proteom 1:845–67
- Baumann S, Ceglarek U, Fiedler GM, et al. (2005). Standradized approach to proteome profiling of human serum based on magnetic bead separation and matrix-assisted laser desorption/ionization time of flight mass spectrometry. Clin Chem 51:973–80
- Bosso N, Chinello C, Picozzi SCM, et al. (2008). Human urine biomarkers of renal cell carcinoma evaluated by ClinProt. Proteom Clin Appl 2:1036–46
- Chang JT, Chen L, Wei S, et al. (2006). Increase diagnostic efficacy by combined use of fingerprint markers in mass spectrometry – plasma peptidomes from nasopharyngeal cancer patients for example. Clin Biochem 39:1144–51
- Cheng A, Chen L, Chien K, et al. (2005). Oral cancer plasma tumor marker identified with beads-based affinity-fractionated proteomic technology. Clin Chem 51:2236–44
- Fan N, Gao C, Zhao G, et al. (2012). Serum peptidome patterns of breast cancer based on magnetic beads separation and mass spectrometry analysis. Diagnos Pathol 7:45. doi: 10.1186/1746-1596-7-45
- Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, Cancer incidence and mortality worldwide: IARC CancerBase No. 11. Lyon: International Agency for Research on Cancer; 2013. Available from: http://globocan.iarc.fr [last accessed Dec 2013]
- Freed GL, Cazares LH, Fichandler CE, et al. (2008). Differential capture of serum proteins for expression profiling and biomarker discovery in pre- and posttreatment head and neck cancer samples. The Laryngoscope 118:61–8
- Jelovac D, Armstrong DK. (2011). Recent progress in the diagnosis and treatment of ovarian Cancer. CA Cancer J Clin 61:183–203
- Kaku T, Ogawa S, Kawano Y. (2003). Histological classification of ovarian cancer. Med Electron Microsc 36:9–17
- Kojima K, Asmellash S, Klug CA, et al. (2008). Applying proteomic-based biomarker tools for the accurate diagnosis of pancreatic cancer. J Gastrointest Surg 12:1683–90
- Lu M, Faull KF, Whitelegge JP, et al. (2007). Proteomics and mass spectrometry for cancer biomarker discovery. Biomarker Insights 2:347–60
- Ornellas P, Ornellas AA, Chinello C, et al. (2012). Downregulation of C3 and C4A/B complement factor fragments in plasma from patients with squamous cell carcinoma of the penis. Int Braz J Urol 38:739–49
- Pan X, Huang L, Chen J, et al. (2012). Analysis of synovial fluid in knee joint of osteoarthritis: 5 proteome patterns of joint inflammation based on matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Inte Orthop (SICOT) 36:57–64
- Qiu F, Liu HY, Dong ZN, et al. (2009). Searching for potential ovarian cancer biomarkers with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Am J Biomed Sci 1: 80–90
- SEER stat fact sheets. Ovary seer.cancer.gov/statfacts/html/ovary.html. [last accessed Sep 2013]
- Shanta V, Swaminathan R. (2008). Population based cancer registry, Chennai, Cancer Institute (WIA), Adyar, individual registry write-up 2006–2008
- Wong MYM, Yu KOY, Poon TCW, et al. (2010). A magnetic beads-based serum proteomic fingerprinting method for parallel analytical analysis and micropreparative purification. Electrophoresis 31:1721–30